elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q63320544-60ABE576-D587-4871-86D1-9FBE47E25433
Q63320544-60ABE576-D587-4871-86D1-9FBE47E25433
BestRank
Statement
http://www.wikidata.org/entity/statement/Q63320544-60ABE576-D587-4871-86D1-9FBE47E25433
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
P6099
Q63320544-60ABE576-D587-4871-86D1-9FBE47E25433
BestRank
Statement
http://www.wikidata.org/entity/statement/Q63320544-60ABE576-D587-4871-86D1-9FBE47E25433
rank
NormalRank
type
BestRank
Statement
P6099
phase II clinical trial